Market closed
Kamada/$KMDA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kamada
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Ticker
$KMDA
Sector
Trading on
Industry
Biotechnology
Headquarters
Rehovot, Israel
Employees
420
Website
Kamada Metrics
BasicAdvanced
$370M
25.12
$0.25
0.21
-
6.37%
Price and volume
Market cap
$370M
Beta
0.21
52-week high
$9.16
52-week low
$4.74
Average daily volume
146K
Financial strength
Current ratio
3.733
Quick ratio
2.137
Long term debt to equity
3.635
Total debt to equity
4.263
Interest coverage (TTM)
30.38%
Management effectiveness
Return on assets (TTM)
3.45%
Return on equity (TTM)
5.74%
Valuation
Price to earnings (TTM)
25.12
Price to revenue (TTM)
2.257
Price to book
5.27
Price to tangible book (TTM)
10.75
Price to free cash flow (TTM)
9.857
Forward dividend yield
6.37%
Growth
Revenue change (TTM)
12.93%
Earnings per share change (TTM)
66.67%
3-year revenue growth (CAGR)
15.80%
3-year earnings per share growth (CAGR)
71.00%
What the Analysts think about Kamada
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Kamada stock.
Kamada Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Kamada Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Kamada News
AllArticlesVideos
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
GlobeNewsWire·2 weeks ago
Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Apr7
Kamada
Dividend·Payment
$0.20
Per share
FAQs
What’s the current market cap for Kamada stock?
Kamada (KMDA) has a market cap of $370M as of April 05, 2025.
What is the P/E ratio for Kamada stock?
The price to earnings (P/E) ratio for Kamada (KMDA) stock is 25.12 as of April 05, 2025.
Does Kamada stock pay dividends?
No, Kamada (KMDA) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Kamada dividend payment date?
Kamada (KMDA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kamada?
Kamada (KMDA) has a beta rating of 0.21. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.